Plasma protein profiles differ between women diagnosed with cervical intraepithelial neoplasia (CIN) 1 and 3

Cancer Informatics

Volumn 2, Issue , 2006, Pages 421-425

  Piyathilake, Chandrika J ^a   Oelschlager, Denise K ^b   Meleth, Sreelatha ^a   Partridge, Edward E ^a   Grizzle, William E ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Cervical; Neoplasia; Protein profiles; SELDI

Indexed keywords

PLASMA PROTEIN; TUMOR PROTEIN;

ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; ADULT; CANCER STAGING; CASE CONTROL STUDY; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION; WOMEN'S HEALTH;

EID: 33846266197     PISSN: 11769351     EISSN: 11769351     Source Type: Journal    
DOI: 10.1177/117693510600200026     Document Type: Article

References (26)

1. ALTS investigators. 2000. Human Papillomavirus Testing for Triage of Women With Cytologic Evidence of Low-Grade Squamous Intraepithelial Lesions: Baseline Data From a Randomized Trial. The ASCUS/LSIL Study (ALTS) Group. JNCI, 92(5):397-402.
2. Bae, S.M., Lee, C.H. and Cho, Y.L. et al. 2005. Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecol. Oncol., 99(1):26-35.
3. Bernard, O.K., Diefenbach, R.D. and Cunningham, L. 2005. New insights into viral structure and virus cell interaction through proteomics. Expert Review of Proteomics, 2:577-588.
4. Engwegen, J.Y., Helgason, H.H. and Cats, A. et al. 2006. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. World J. Gastroenterol., 12(10):1536-44.
5. Ho, D.W., Yang, Z.F. and Wong, B.Y. et al. 2006. Surface enhanced laser desorption/ionization time-of-flight mass spectrometry serum protein profiling to identify nasopharyngeal carcinoma. Cancer, 107(1): 99-107.
6. Langbein, S., Lehmann, J. and Harder, A. et al. 2006. Protein profiling of bladder cancer using the 2D-PAGE and Seldi-TOF-MS technique. Technol. Cancer Res., Treat, 5(1):67-72.
7. Lawrie, L.C., Curran, S. and McLeod, H.L. et al. 2001. Application of laser capture microdissection and proteomics in colon cancer. Mol. Pathol., 54(4):253-8.
8. Liang, Y., Fang, M. and Li, J. et al. 2006. Serum Proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry. Exp. Mol. Pathol., 81:176-180.
9. Lin, Y.W., Lin, C.Y. and Lai, H.C. et al. 2006. Plasma Proteomic pattern as biomarkers for ovarian cancer. Int. J. Gynecol. Cancer, 16 Suppl 1:139-46.
10. Walsh, J.M. 1998. Cervical cancer: developments in screening and evaluation of the abnormal Pap smear. The Western Journal Of Medicine, 169:304-310.
11. Paavaonen, J., Koutsky, L.A. and Kiviat, N.B. 1990. Cervical neoplasia and other STD-related genital and ana neoplasias. In: Holmes, K.K., Mardh, P.A., Sparling, P.F., Wiesner, P.J., editors. Sexually transmitted disease. 2nd ed. New York (NY): McGraw-Hill; p. 561-92.
12. Paweletz, C.P., Trock, B. and Pennanen, M. et al. 2001. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: Potential for new biomarkers to aid in the diagnosis of breast cancer. DIS Markers, 17 (4):301-7.
13. Piyathilake, C.J., Henao, O.L. and Macaluso, M. et al. 2004. Folate is associated with the natural history of high-risk human papillomaviruses. Cancer Res., 64(23):8788-93.
14. Qu, Y., Adam, B.L. and Yasui, Y. et al. 2002. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from non-cancer patients. Clin. Chem., 48(10):1835-43.
15. Roesch-Ely, M., Nees, M. and Karsai S. et al. 2006. Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. Oncogene, advance online publication 3:DOI:10.1038/sj.onc.1209770.
16. Schechter, C.B., 1996. Cost-effectiveness of re-screening conventionally prepared cervical smears by PAPNET testing. Acta. Cytol., 40(6): 1272-82.
17. Solomon, D., Schiffman, M. and Tarone, R., for the ALTS Group. 2001. Comparison of Three Management Strategies for Patients with Atypical Squamous Cells of Undetermined Significance. Baseline Results from a randomized trial. JNCI, 92(12):293-299.
18. Srinivas, P.R., Srivastava, S. and Hanash, S. et al. 2001. Proteomics in early detection of cancer. Clin. Chem., 47:1901-11.
19. Streckfus, C.F., Bigler, L.R. and Zwick, M. 2006. The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: a feasibility study. J. Oral Pathol. Med., 35(5):292-300.
20. Waghray, A., Feroze, F. and Schober, M.S. et al. 2001. Identification of androgen-regulated genes in the prostate cancer cell line LNCaP by serial analysis of gene expression and proteomic analysis. Proteomics, 10:1327-38.
21. Ward, D.G., Cheng, Y. and N'Kontchou, G. et al. 2006. Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis. Br. J. Cancer, 94(2):87-92.
22. Ward, D.G., Suggett, N. and Cheng, Y. et al. 2006. Identification of serum biomarkers for colon cancer by proteomic analysis. Br. J. Cancer, 94 (12):1898-905.
23. Wong, Y.F., Cheung, T.H. and Lo, K.W. et al. 2004. Protein profiling of cervical cancer by protein-biochips: proteomic scoring to discriminate cervical cancer from normal cervix. Cancer Lett., 211(2):227-34.
24. Wright, Jr., G.L., Cazares, L.H. and Leung, S.M. et al. 1999. Proteinchip surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer and Prostatic Diseases, 2:264-276.
25. Wulfkuhle, J.D., McLean, K.C. and Paweletz, C.P. et al. 2001. New approaches to proteomic analysis of breast cancer. Proteomics, 10: 1205-15.
26. Zhu, L.R., Zhang, W.Y. and Yu, L. et al. 2006. Serum proteomic features for detection of endometrial cancer. Int. J. Gynecol. Cancer, 16(3): 1374-8.